Natural products as a novel therapeutic strategy for NLRP3 inflammasome-mediated gout

JH Lee, HS Kim, JH Lee, G Yang, HJ Kim - Frontiers in Pharmacology, 2022 - frontiersin.org
Gout is the most common form of inflammatory arthritis. It occurs when monosodium urate
crystals (MSU) are deposited within joints due to hyperuricemia and persistent elevations of …

Beneficial properties of phytochemicals on NLRP3 inflammasome-mediated gout and complication

JJ Jhang, JH Lin, GC Yen - Journal of agricultural and food …, 2018 - ACS Publications
Gouty arthritis is characterized by the precipitation of monosodium urate (MSU) crystals in
the joint. Pro-inflammatory cytokine IL-1β is a critical manifestation in response to MSU …

[HTML][HTML] The mechanism of the NLRP3 inflammasome activation and pathogenic implication in the pathogenesis of gout

SK Kim - Journal of Rheumatic Diseases, 2022 - ncbi.nlm.nih.gov
Abstract The NACHT, LRR, and PYD-domains-containing protein 3 (NLRP3) inflammasome
is an intracellular multi-protein signaling platform that is activated by cytosolic pattern …

[HTML][HTML] Role of NLRP3 in the pathogenesis and treatment of gout arthritis

Y Liu, J Wang, J Li - Frontiers in Immunology, 2023 - frontiersin.org
Gout arthritis (GA) is a common and curable type of inflammatory arthritis that has been
attributed to a combination of genetic, environmental and metabolic factors. Chronic …

The NLRP3 inflammasome-interleukin 1 pathway as a therapeutic target in gout

Z Szekanecz, S Szamosi, GE Kovács, E Kocsis… - Archives of biochemistry …, 2019 - Elsevier
The NLRP3 inflammasome is implicated in the processing of the pro-inflammatory cytokine
interleukin 1β. Inflammatory disorders associated with the activation of the NLRP3 …

Ameliorative effects of cardamonin on monosodium urate-induced gouty arthritis through inhibiting NLRP3 inflammasome mediation

CC Wang, JW Lu, YJ Peng, CH Lee, HS Lee, YH Chu… - Medicina, 2021 - mdpi.com
Background and Objectives: Gouty arthritis is an acute inflammatory response caused by the
precipitation of monosodium urate (MSU) crystals in joints. The triggering of MSU leads to …

Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout

HE Lee, G Yang, ND Kim, S Jeong, Y Jung, JY Choi… - Scientific reports, 2016 - nature.com
Gouty arthritis is caused by the deposition of uric acid crystals, which induce the activation of
NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome. The NLRP3 …

Tetrahydropalmatine attenuates MSU crystal-induced gouty arthritis by inhibiting ROS-mediated NLRP3 inflammasome activation

Y Wang, W Zhu, D Lu, C Zhang, Y Wang - International …, 2021 - Elsevier
Activation of NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome
plays a crucial role in the inflammatory responses of monosodium urate (MSU) crystal …

A novel NLRP3 inhibitor as a therapeutic agent against monosodium urate-induced gout

K Park, I Shin, Y Kim, H Kang, SJ Oh, E Jang… - Frontiers in …, 2024 - frontiersin.org
Background Since NEK7 is critical for NLRP3 inflammasome activation, NEK7 inhibitors
could be employed as therapeutic agents against gout, a representative disease caused by …

Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation

G Yang, SH Yeon, HE Lee, HC Kang, YY Cho… - …, 2018 - academic.oup.com
Objective The aetiology of gout is closely linked to the deposition of monosodium uric acid
(MSU) crystals and the consequent activation of the NOD-like receptor family, pyrin domain …